Cargando…

Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey

OBJECTIVE: To examine the impact of self‐reported human papillomavirus (HPV) test result (HPV negative, HPV positive, HPV result unknown) on a range of psychosocial outcomes. METHODS: Women and other people with a cervix in Australia aged 25–74 years who reported having participated in cervical scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chadwick, Verity, Bennett, Kirsty F., McCaffery, Kirsten J., Brotherton, Julia M. L., Dodd, Rachael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546150/
https://www.ncbi.nlm.nih.gov/pubmed/35128756
http://dx.doi.org/10.1002/pon.5897
_version_ 1784804978558238720
author Chadwick, Verity
Bennett, Kirsty F.
McCaffery, Kirsten J.
Brotherton, Julia M. L.
Dodd, Rachael H.
author_facet Chadwick, Verity
Bennett, Kirsty F.
McCaffery, Kirsten J.
Brotherton, Julia M. L.
Dodd, Rachael H.
author_sort Chadwick, Verity
collection PubMed
description OBJECTIVE: To examine the impact of self‐reported human papillomavirus (HPV) test result (HPV negative, HPV positive, HPV result unknown) on a range of psychosocial outcomes. METHODS: Women and other people with a cervix in Australia aged 25–74 years who reported having participated in cervical screening since December 2017 were recruited through Facebook and Instagram to complete an online survey. The primary outcome measures were anxiety, emotional distress, and general distress. RESULTS: Nine hundred fifteen participants completed the online survey; 73.2% reported testing HPV negative (‘HPV−’), 15% reported testing HPV positive (‘HPV+’) and 11.8% reported that they did not know/remember their test result (‘HPV unknown’). Compared to participants testing HPV−, participants testing HPV+ had higher mean anxiety (41.67 vs. 37.08, p < 0.001) and emotional distress scores (11.88 vs. 7.71, p < 0.001). Concern about test result (34.3% vs. 1.3%, p < 0.001), perceived risk compared to average women (55.4% vs. 14.1%, p < 0.001), and cancer worry (27.8% vs. 5.9%, p < 0.001) were also greater among HPV+ participants than participants testing HPV−. Participants testing HPV+ felt less reassured about their screening result than participants testing HPV− (16% vs. 75.1%, p < 0.001). Participants testing HPV+ had greater knowledge of HPV (11.96 vs. 10.36 out of 16, p < 0.001) and HPV testing (3.94 vs 3.28 out of 5, p < 0.001) than participants who reported testing HPV−. CONCLUSIONS: Elevated levels of anxiety and emotional distress were found in those testing HPV+ compared with those testing HPV−. Future research should examine what strategies should be used to deliver test results and what additional information is provided, in order to alleviate anxiety among individuals testing HPV+.
format Online
Article
Text
id pubmed-9546150
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95461502022-10-14 Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey Chadwick, Verity Bennett, Kirsty F. McCaffery, Kirsten J. Brotherton, Julia M. L. Dodd, Rachael H. Psychooncology Original Articles OBJECTIVE: To examine the impact of self‐reported human papillomavirus (HPV) test result (HPV negative, HPV positive, HPV result unknown) on a range of psychosocial outcomes. METHODS: Women and other people with a cervix in Australia aged 25–74 years who reported having participated in cervical screening since December 2017 were recruited through Facebook and Instagram to complete an online survey. The primary outcome measures were anxiety, emotional distress, and general distress. RESULTS: Nine hundred fifteen participants completed the online survey; 73.2% reported testing HPV negative (‘HPV−’), 15% reported testing HPV positive (‘HPV+’) and 11.8% reported that they did not know/remember their test result (‘HPV unknown’). Compared to participants testing HPV−, participants testing HPV+ had higher mean anxiety (41.67 vs. 37.08, p < 0.001) and emotional distress scores (11.88 vs. 7.71, p < 0.001). Concern about test result (34.3% vs. 1.3%, p < 0.001), perceived risk compared to average women (55.4% vs. 14.1%, p < 0.001), and cancer worry (27.8% vs. 5.9%, p < 0.001) were also greater among HPV+ participants than participants testing HPV−. Participants testing HPV+ felt less reassured about their screening result than participants testing HPV− (16% vs. 75.1%, p < 0.001). Participants testing HPV+ had greater knowledge of HPV (11.96 vs. 10.36 out of 16, p < 0.001) and HPV testing (3.94 vs 3.28 out of 5, p < 0.001) than participants who reported testing HPV−. CONCLUSIONS: Elevated levels of anxiety and emotional distress were found in those testing HPV+ compared with those testing HPV−. Future research should examine what strategies should be used to deliver test results and what additional information is provided, in order to alleviate anxiety among individuals testing HPV+. John Wiley and Sons Inc. 2022-02-12 2022-07 /pmc/articles/PMC9546150/ /pubmed/35128756 http://dx.doi.org/10.1002/pon.5897 Text en © 2022 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Chadwick, Verity
Bennett, Kirsty F.
McCaffery, Kirsten J.
Brotherton, Julia M. L.
Dodd, Rachael H.
Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey
title Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey
title_full Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey
title_fullStr Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey
title_full_unstemmed Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey
title_short Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey
title_sort psychosocial impact of testing human papillomavirus positive in australia's human papillomavirus‐based cervical screening program: a cross‐sectional survey
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546150/
https://www.ncbi.nlm.nih.gov/pubmed/35128756
http://dx.doi.org/10.1002/pon.5897
work_keys_str_mv AT chadwickverity psychosocialimpactoftestinghumanpapillomaviruspositiveinaustraliashumanpapillomavirusbasedcervicalscreeningprogramacrosssectionalsurvey
AT bennettkirstyf psychosocialimpactoftestinghumanpapillomaviruspositiveinaustraliashumanpapillomavirusbasedcervicalscreeningprogramacrosssectionalsurvey
AT mccafferykirstenj psychosocialimpactoftestinghumanpapillomaviruspositiveinaustraliashumanpapillomavirusbasedcervicalscreeningprogramacrosssectionalsurvey
AT brothertonjuliaml psychosocialimpactoftestinghumanpapillomaviruspositiveinaustraliashumanpapillomavirusbasedcervicalscreeningprogramacrosssectionalsurvey
AT doddrachaelh psychosocialimpactoftestinghumanpapillomaviruspositiveinaustraliashumanpapillomavirusbasedcervicalscreeningprogramacrosssectionalsurvey